1Mzzaferri EL,Yong RL,Oertel JE,et al.Papillary thyroid carcimoma:the impact of therapy in 576 patients.Medicine(Baltimore),1977,56(3):171-196 被引量：2
2Mazzaferri EL.Long-term outcome of patients with differentiated thyroid carcinoma:Effect of therapy.Endocr Pract,2000,6(6):469-476 被引量：2
3Gemsenjager E,Heitz PU,Martina B,et al.Therapy concept in differentiated thyroid gland carcinoma-results of 25 years with 257 patients.Schweiz Rundsch Med Prax,2000,89(44):1779-1797 被引量：2
4Beierwaltes WH.Radioiodine therapy of thyroid disease Int J Rad Appl Instrum B.Med Biol,1987,14(3):177-181 被引量：2
5Schlumberger MJ.Papillary and follicular thyroid carcinoma.N Engl J Med,1998,338(5):297-306 被引量：2
6Fujiwara H,Tatsumi K,Tanaka S,et al.A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect.Thyroid,2000,10(6):471-474 被引量：2
7Pohlenz J,Refetoff S.Mutations in the sodium-iodide symporter(NIS) gene as a cause for iodide transport defects and congenital hypothyroidism.Biochimie,1999,81(5):469-476 被引量：1
8Smanik PA,Liu Q,Furminger TL,et al.Cloning of the human sodium lodide symporter.Biochem Biophys Res Commun,1966,226(2):339-345 被引量：1
9Hansen LA,Sigman CC,Andreola F,et al.Retinoids in chemoprevention and differentiation therapy.Carcinogenesis,2000,21(7):1271-1279 被引量：1
10Schmutzler C,Winzer R,Meissner-Weigl J,et al.Retinoic and increases Na/I symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.Biochem Biophys Res Commun,1997, 被引量：1
